A randomized study of adefovir dipivoxil in place of HBIG in combination with lamivudine as post–liver transplantation hepatitis B prophylaxis

Cited in:

CrossRef

This article has been cited by:

1. 1
   Wai-Kay Seto, Ching-Lung Lai, Man-Fung Yuen, Acute-on-chronic liver failure in chronic hepatitis B, Journal of Gastroenterology and Hepatology, 2012, 27, 4

   Direct Link:

   • Abstract
   • Full Article (HTML)
   • PDF(220K)
   • References
2. 2
   Maria C Segovia, Wadih Chacra, Stuart C Gordon, Adefovir dipivoxil in chronic hepatitis B: history and current uses, Expert Opinion on Pharmacotherapy, 2012, 13, 2, 245

   CrossRef

3. 3
   Yun-Fan Liaw, Jia-Horng Kao, Teerha Piratvisuth, Henry Lik Yuen Chan, Rong-Nan Chien, Chun-Jen Liu, Ed Gane, Stephen Locarnini, Seng-Gee Lim, Kwang-Hyub Han, Deepak Amarapurkar, Graham Cooksley, Wasim Jafri, Rosmawati Mohamed, Jin-Lin Hou, Wan-Long Chuang, Laurentius A. Lesmana, Jose D. Sollano, Dong-Jin Suh, Masao Omata, Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update, Hepatology International, 2012, 6, 3, 531

   CrossRef

4. 4
   E. Cholongitas, T. Vasiliadis, N. Antoniadis, I. Goulis, V. Papanikolaou, E. Akriviadis, Hepatitis B prophylaxis post liver transplantation with newer nucleos(t)ide analogues after hepatitis B immunoglobulin discontinuation, Transplant Infectious Disease, 2012, 14, 2

   Direct Link:

   • Abstract
   • Full Article (HTML)
   • PDF(114K)
   • References
5. 5
   Marie A. Laryea, Kymberly D. Watt, Immunoprophylaxis against and prevention of recurrent viral hepatitis after liver transplantation, Liver Transplantation, 2012, 18, 5

   Direct Link:

   • Abstract
   • Full Article (HTML)
   • PDF(774K)
   • References
6. 6
   Andres F. Carrion, Paul Martin, Christopher O’Brien, Management of Patients with Chronic Hepatitis B Before and After Liver Transplantation: An Update, Current Hepatitis Reports, 2012, 11, 2, 102

   CrossRef

7. 7
   Kai Wang, Zhi-Jun Zhu, Hong Zheng, Yong-Lin Deng, Cheng Pan, Li-Ying Sun, Zhong-Yang Shen, Protective hepatitis B surface antibodies in blood and ascites fluid in the early stage after liver transplantation for hepatitis B diseases, Hepatology Research, 2012, 42, 3

   Direct Link:

   • Abstract
   • Full Article (HTML)
   • PDF(308K)
   • References
8. 8
   James Fung, Chung-Mau Lo, Reply, Gastroenterology, 2012, 142, 1, e34

   CrossRef

9. 9
   Bart van Hoek, Bert-Jan de Rooij, Hein W. Verspaget, Risk factors for infection after liver transplantation, Best Practice & Research Clinical Gastroenterology, 2012, 26, 1, 61

   CrossRef

10. 10
    R. Todd Stravitz, Mitchell L. Shiffman, Melissa Kimmel, Puneet Puri, Velimir A. Luketic, Richard K. Sterling, Arun J. Sanyal, Adrian H. Cotterell, Marc P. Posner, Robert A. Fisher, Substitution of tenofovir/emtricitabine for Hepatitis B immune globulin prevents recurrence of Hepatitis B after liver transplantation, Liver International, 2012, 32, 5

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(200K)
    • References
11. 11
    Alyson N. Fox, Norah A. Terrault, The option of HBIG-free prophylaxis against recurrent HBV, Journal of Hepatology, 2012, 56, 5, 1189

    CrossRef

12. 12
    Jennifer C. Lai, Norah A. Terrault, Zakim and Boyer's Hepatology, 2012,

    CrossRef

13. 13
    Xiao Xu, Zhenhua Tu, Bei Wang, Qi Ling, Lin Zhang, Lin Zhou, Guoping Jiang, Jian Wu, Shusen Zheng, A novel model for evaluating the risk of hepatitis B recurrence after liver transplantation, Liver International, 2011, 31, 10

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(304K)
    • References
14. 14
    Corinne Buchanan, Tram T. Tran, Current Status of Liver Transplantation for Hepatitis B Virus, Clinics in Liver Disease, 2011, 15, 4, 753

    CrossRef

15. 15
    Li-Chun Wang, En-Qiang Chen, Jing Cao, Li Liu, Li Zheng, Da-Jiang Li, Lu Xu, Xue-Zhong Lei, Cong liu, Hong Tang, De novo combination of lamivudine and adefovir versus entecavir monotherapy for the treatment of naïve HBeAg-negative chronic hepatitis B patients, Hepatology International, 2011, 5, 2, 671

    CrossRef

16. 16
    James Fung, Cindy Cheung, See–Ching Chan, Man–Fung Yuen, Kenneth S.H. Chok, William Sharr, Wing–Chiu Dai, Albert C.Y. Chan, Tan–To Cheung, Simon Tsang, Banny Lam, Ching–Lung Lai, Chung–Mau Lo, Entecavir Monotherapy Is Effective in Suppressing Hepatitis B Virus After Liver Transplantation, Gastroenterology, 2011, 141, 4, 1212

    CrossRef

17. 17
    Matthew S. Chang, Robert S. Brown, Hepatitis B and Liver Transplantation: Update in Management before and after Transplantation, Current Hepatitis Reports, 2011, 10, 4, 255

    CrossRef

18. 18
    Evangelos Cholongitas, John Goulis, Evangelos Akriviadis, Geore V. Papatheodoridis, Hepatitis B immunoglobulin and/or nucleos(t)ide analogues for prophylaxis against hepatitis b virus recurrence after liver transplantation: A systematic review, Liver Transplantation, 2011, 17, 10

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(395K)
    • References
19. 19
    Stephen E Congly, Kelly W Burak, Carla S Coffin, Hepatitis B immunoglobulin for prevention of hepatitis B virus infection and recurrence after liver transplantation, Expert Review of Clinical Immunology, 2011, 7, 4, 429

    CrossRef

20. 20
    Alyson N. Fox, Norah A. Terrault, Individualizing hepatitis B infection prophylaxis in liver transplant recipients, Journal of Hepatology, 2011, 55, 3, 507

    CrossRef

21. 21
    Hatef Massoumi, Paul Martin, Hui-Hui Tan, Management of chronic hepatitis B, European Journal of Gastroenterology & Hepatology, 2011, 23, 8, 642

    CrossRef

22. 22
    Alfredo Marzano, Management of HBV resistance in the post-transplant setting, Digestive and Liver Disease Supplements, 2011, 5, 1, 19

    CrossRef

23. 23
    James Fung, Managing hepatitis B: Before and after liver transplantation, Indian Journal of Transplantation, 2011, 5, 2, 77

    CrossRef

24. 24
    Paolo De Simone, Optimization of hepatitis B virus prophylaxis after liver transplantation, Digestive and Liver Disease Supplements, 2011, 5, 1, 15

    CrossRef

25. 25
    Jamie L. Berkes, Post-transplant Management of Hepatitis B: Can We Dispense with Hepatitis B Immunoglobulin?, Current Hepatitis Reports, 2011, 10, 2, 142

    CrossRef

26. 26
    S. Saab, S. Desai, D. Tsaoi, F. Durazo, S. Han, A. McClune, C. Holt, D. Farmer, L. Goldstein, R. W. Busuttil, Posttransplantation Hepatitis B Prophylaxis with Combination Oral Nucleoside and Nucleotide Analog Therapy, American Journal of Transplantation, 2011, 11, 3

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(94K)
    • References
27. 27
    T. Karlas, J. Hartmann, A. Weimann, M. Maier , M. Bartels, S. Jonas, J. Mössner, T. Berg, H.L. Tillmann, J. Wiegand, Prevention of lamivudine-resistant hepatitis B recurrence after liver transplantation with entecavir plus tenofovir combination therapy and perioperative hepatitis B immunoglobulin only, Transplant Infectious Disease, 2011, 13, 3

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(161K)
    • References
28. 28
    Geoffrey W. McCaughan, Prevention of post liver transplant HBV recurrence, Hepatology International, 2011, 5, 4, 876

    CrossRef

29. 29
    Arianeb Mehrabi, Majid Esmaeilzadeh, Hamidreza Fonouni, Mohammadreza Hafezi, Nuh N. Rahbari, Mohammad Golriz, Ali Majlesara, Morva Tahmasbi Rad, Mahmoud Sadeghi, Jan Schmidt, Tom M. Ganten, The role of HBIg as hepatitis B reinfection prophylaxis following liver transplantation, Langenbeck's Archives of Surgery, 2011, 397, 5, 697

    CrossRef

30. 30
    Irene N Rapti, Stephanos J Hadziyannis, Treatment of special populations with chronic hepatitis B infection, Expert Review of Gastroenterology & Hepatology, 2011, 5, 3, 323

    CrossRef

31. 31
    Lynne Strasfeld, Sunwen Chou, Antiviral Drug Resistance: Mechanisms and Clinical Implications, Infectious Disease Clinics of North America, 2010, 24, 3, 809

    CrossRef

32. 32
    Lynne Strasfeld, Sunwen Chou, Antiviral Drug Resistance: Mechanisms and Clinical Implications, Infectious Disease Clinics of North America, 2010, 24, 2, 413

    CrossRef

33. 33
    Ed Gane, Hepatitis B immunoglobulin immunoprophylaxis for hepatitis B: High, low, or no dose?, Liver Transplantation, 2010, 16, S2

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(80K)
    • References
34. You have free access to this content34
    Jie Chen, Liping Yi, Ji Dong Jia, Hong Ma, Hong You, Hepatitis B immunoglobulins and/or lamivudine for preventing hepatitis B recurrence after liver transplantation: A systematic review, Journal of Gastroenterology and Hepatology, 2010, 25, 5

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(123K)
    • References
35. 35
    Bruno Roche, Didier Samuel, Hepatitis: Viral load predicts HBV recurrence after liver transplant, Nature Reviews Gastroenterology & Hepatology, 2010, 7, 12, 657

    CrossRef

36. 36
    Florian Bihl, Stefan Russmann, Vanina Gurtner, Loriana Di Giammarino, Loredana Pizzi-Bosman, Martine Michel, Andreas Cerny, Antoine Hadengue, Pietro Majno, Emiliano Giostra, Damiano Castelli, Gilles Mentha, Hyperimmune anti-HBs plasma as alternative to commercial immunoglobulins for prevention of HBV recurrence after liver transplantation, BMC Gastroenterology, 2010, 10, 1, 71

    CrossRef

37. 37
    B. Degertekin, Steven-Huy B. Han, E. B. Keeffe, E. R. Schiff, V. A. Luketic, R. S. Brown, Jr., S. Emre, C. Soldevila-Pico, K. R. Reddy, M. B. Ishitani, T. T. Tran, T. L. Pruett, A. S. F. Lok, Impact of Virologic Breakthrough and HBIG Regimen on Hepatitis B Recurrence After Liver Transplantation, American Journal of Transplantation, 2010, 10, 8

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(274K)
    • References
38. 38
    E. Gane, Posttransplant Prophylaxis Strategies for Hepatitis B, American Journal of Transplantation, 2010, 10, 8

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(36K)
    • References
39. 39
    Paul Martin, Hugo R. Rosen, Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 2010,

    CrossRef

40. 40
    MARGARET JAMES KOZIEL, CHLOE LYNNE THIO, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 2010,

    CrossRef

41. 41
    Geoff McCaughan, Advances in viral hepatitis: 50 years of Australian gastroenterology, Journal of Gastroenterology and Hepatology, 2009, 24,

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(85K)
    • References
42. 42
    Nicholas K. Weber, Lisa M. Forman, James F. Trotter, HBIg Discontinuation with Maintenance Oral Anti-viral Therapy and HBV Vaccination in Liver Transplant Recipients, Digestive Diseases and Sciences, 2009, 55, 2, 505

    CrossRef

43. 43
    Maki Yamamoto, Gregg Little, David K Imagawa, Hepatitis B immunoglobulin in preventing reinfection following liver transplantation, Expert Review of Anti-infective Therapy, 2009, 7, 3, 321

    CrossRef

44. 44
    Anne Marie Roque-Afonso, Hepatitis B virus cellular immunity after liver transplantation: A role in preventing hepatitis B virus recurrence?, Liver Transplantation, 2009, 15, 3

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(67K)
    • References
45. 45
    Imre Fehérvári, Májátültetés, Magyar Sebészet (Hungarian Journal of Surgery), 2009, 62, 4, 251

    CrossRef

46. 46
    Lawrie W Powell, Overview: Liver disease and transplantation, Journal of Gastroenterology and Hepatology, 2009, 24,

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(172K)
    • References
47. 47
    L. Castells, I. Campos-Varela, M. Buti, R. Esteban, Pharmacokinetics of intramuscular and intravenous HBIG: Which implications for practice?, Digestive and Liver Disease Supplements, 2009, 3, 4, 119

    CrossRef

48. 48
    Scott J Patterson, Peter W Angus, Post-liver transplant hepatitis B prophylaxis: the role of oral nucleos(t)ide analogues, Current Opinion in Organ Transplantation, 2009, 14, 3, 225

    CrossRef

49. 49
    M. Buti, L. Castells, I. Campos, R. Esteban, Prevention of HBV recurrence after liver transplant: The role of combination therapy, Digestive and Liver Disease Supplements, 2009, 3, 4, 98

    CrossRef

50. 50
    Marion G. Peters, Special populations with hepatitis B virus infection, Hepatology, 2009, 49, S5

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(382K)
    • References
51. 51
    Lior H Katz, Ran Tur-Kaspa, Daniel G Guy, Mical Paul, Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation, The Cochrane Library,

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(501K)
    • References
52. 52
    Norah Terrault, Liver Transplantation in Patients with Hepatitis B, C or HIV Infection,

    Direct Link:

    • Summary
    • PDF(14563K)
    • References
53. 53
    Evangelos Cholongitas, George V Papatheodoridis, Management of HBV Infection and Liver Transplantation,

    Direct Link:

    • Summary
    • PDF(574K)
    • References
54. 54
    Ed Gane, Prevention and Treatment of Recurrent HBV and HCV Infection,

    Direct Link:

    • Summary
    • PDF(89K)
    • References
55. 55
    Geoffrey W. McCaughan, Viral Hepatitis and Transplantation,

    Direct Link:

    • Summary
    • PDF(78K)
    • References